Fresenius SE & Co. (OTCMKTS:FSNUY) Sees Significant Decrease in Short Interest

Posted by on May 30th, 2026

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) was the target of a large decline in short interest in May. As of May 15th, there was short interest totaling 49,381 shares, a decline of 65.8% from the April 30th total of 144,231 shares. Based on an average daily volume of 338,840 shares, the days-to-cover ratio is currently 0.1 days. Approximately 0.0% of the shares of the company are sold short.

Fresenius SE & Co. Price Performance

Shares of OTCMKTS FSNUY traded down $0.14 during mid-day trading on Friday, reaching $10.64. The company had a trading volume of 156,060 shares, compared to its average volume of 179,826. The firm has a market cap of $23.97 billion, a price-to-earnings ratio of 14.19 and a beta of 0.68. The business’s 50-day simple moving average is $12.23 and its 200 day simple moving average is $13.57. Fresenius SE & Co. has a one year low of $10.60 and a one year high of $33.93. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.00 and a current ratio of 1.32.

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $0.24 earnings per share for the quarter, missing the consensus estimate of $0.25 by ($0.01). The firm had revenue of $6.75 billion for the quarter, compared to the consensus estimate of $6.79 billion. Fresenius SE & Co. had a return on equity of 10.29% and a net margin of 6.55%. On average, research analysts predict that Fresenius SE & Co. will post 1.05 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the stock. Morgan Stanley restated an “overweight” rating on shares of Fresenius SE & Co. in a research report on Monday, April 20th. Citigroup reiterated a “buy” rating on shares of Fresenius SE & Co. in a research report on Tuesday, February 3rd. Three equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Buy”.

Get Our Latest Stock Analysis on FSNUY

About Fresenius SE & Co.

(Get Free Report)

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.

Featured Articles

Receive News & Ratings for Fresenius SE & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co. and related companies with MarketBeat.com's FREE daily email newsletter.